Market Data on both Smart Phone and Paper
Markets

Weekly CFO Sells Highlight: Tyson Foods, Alexion Pharmaceuticals, Gilead Sciences

According to GuruFocus Insider Data, the recent CFO sales were: Tyson Foods Inc. ( TSN ), Alexion Pharmaceuticals Inc. ( ALXN ) and Gilead Sciences Inc. ( GILD ).

Tyson Foods Inc.: EVP and CFO Dennis Leatherby sold 110,966 shares

On Dec. 2, EVP and CFO Dennis Leatherby sold 110,966 shares at an average price of $50.71. The price of the stock has increased by 3.57%. Tyson Foods Inc. has a market cap of $19.2 billion and its shares were traded at around $52.52. The company has a P/E ratio of 17.73 and P/S ratio of 0.52 with a dividend yield of 0.86%. Over the past 10 years, Tyson Foods Inc. had an annual average earnings growth of 12.80%.

Tyson Foods announced its 2015 third-quarter results with revenues of $10.51 billion and gross profit of $986 million; the net income was $258 million. The 2015 total revenue was $41.37 billion, a 10% increase from the 2014 total revenue. The 2015 gross profit was $3.92 billion, a 46% increase from the 2014 gross profit. The 2015 net income was $1.22 billion.

On Nov. 30, President and CEO Donald Smith ( Trades , Portfolio ) sold 102,901 shares at an average price of $50. The price of the stock has increased by 5.04%. On Nov. 27, Director Antonio Berlanga, bought 18,500 shares at an average price of 11 cents per share. The price of the stock has increased by 5.04%. On Dec. 9, Director Jim D. Kever sold 5,000 shares at an average price of $52.65. The price of the stock has decreased by 0.25%.

Alexion Pharmaceuticals Inc.: EVP and CFO Vikas Sinha sold 675 shares

On Aug. 4, EVP and CFO Vikas Sinha sold 675 shares at an average price of $196.52 per share. The price of the stock has decreased by 4.3%. Alexion Pharmaceuticals Inc. has a market cap of $42.37 billion and its shares were traded at around $188.06. The company has a P/E ratio of 153.01 and P/S ratio of 15.73. Over the past five years, Alexion Pharmaceuticals Inc. had an annual average earnings growth of 52.30%.

Alexion Pharmaceuticals Inc. announced its 2015 third-quarter results with revenues of $666.64 million and gross profit of $612.58 million. The 2014 total revenue was $2.23 billion, a 44% increase from the 2013 total revenue. The 2014 gross profit was $2.06 billion, a 50% increase from the 2013 gross profit. The 2014 net income was $656.91 million.

On Aug. 7, CEO David Hallal sold 329 shares at an average price of $190.01 per share. The price of the stock has decreased by 1.03%. On Dec. 8, Director Leonard Bell sold 70,000 shares at an average price of $188.2. The price of the stock has decreased by 0.07%. On Dec. 8, EVP, Chief Strat and Port. Off. Saqib Islam sold 950 shares at an average price of $190. The price of the stock has decreased by 1.02%.

Gilead Sciences Inc.: EVP and CFO Robin L Washington sold 6,250 shares

On Nov. 2, EVP and CFO Robin L Washington sold 6,250 shares at an average price of $109.46. The price of the stock has decreased by 8.62%. Gilead Sciences Inc. has a market cap of $144.16 billion and its shares were traded at around $100.03. The company has a P/E ratio of 9.15 and P/S ratio of 4.94 with a dividend yield of 0.86%. Over the past five years, Gilead Sciences Inc. had an annual average earnings growth of 27.20%.

Gilead Sciences announced its 2015 third-quarter results with revenues of $8.30 billion and gross profit of $7.23 billion; the net income was $4.6 billion. The 2014 total revenue was $24.89 billion, a 122% increase from the 2013 total revenue. The 2014 gross profit was $21.10 billion, a 153% increase from the 2013 gross profit. The 2014 net income was $12.10 billion.

On Dec. 1, Chairman and CEO John C Martin sold 150,000 shares at an average price of $105.82. The price of the stock has decreased by 5.47%. On Dec. 7, President and COO John F Milligan sold 100,000 shares at an average price of $103.18. The price of the stock has decreased by 3.05%. On Dec. 1, EVP, Corp and Med Affairs Gregg H Alton sold 12,000 shares at an average price of $106.01. The price of the stock has decreased by 5.64%.

Read More:

About GuruFocus: GuruFocus.com tracks the stocks picks and portfolio holdings of the world's best investors. This value investing site offers stock screeners and valuation tools. And publishes daily articles tracking the latest moves of the world's best investors. GuruFocus also provides promising stock ideas in 3 monthly newsletters sent to Premium Members .

This article first appeared on GuruFocus .

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

GILD ALXN TSN

Other Topics

Stocks

Latest Markets Videos